No Data
No Data
Shenzhen Mindray Bio-Medical Electronics (300760.SZ): By the end of this year, the company will launch the industry's first critical care decision support system based on AI big model technology.
In the clinical perspective, a new parameter or new technology of a medical monitor or anesthesia machine is no longer attractive enough to replace the existing equipment. However, with the integration of IT+AI, more accurate diagnosis and treatment plans, more efficient work efficiency, and more attentive patient care will impress clinical users and decision makers more effectively. At the end of this year, the company will also release the industry's first intensive care decision support system based on AI big model technology, with the goal of becoming an intelligent assistant for intensive care medical staff, and subsequent enhancements through continuous data.
Research Reports Uncover Gold | Guosen Securities: Maintains shenzhen mindray bio-medical electronics' "Outperform" rating, outstanding performance in the in vitro diagnostics business.
Guosen Securities research reports pointed out that Mindray Bio-Medical Electronics (300760.SZ) achieved revenue of 11.16 billion yuan (+10.4%) in the second quarter, with a net income of 4.4 billion yuan (+13.7%) attributable to the parent company. After excluding the impact of exchange gains and losses, the growth rate was 24%. In the first half of 2024, the growth was driven by the in vitro diagnostic business, and the ultrasound business broke through the high-end market. The in vitro diagnostic business achieved a revenue of 7.658 billion yuan (+28.16%) in the first half of the year, with the chemical luminescence business growing by more than 30%. The domestic in vitro diagnostic business grew by more than 25% in the first half of the year, with the domestic hematology business growing by more than 30%. Medical imaging business
Results: Shenzhen Mindray Bio-Medical Electronics Co., Ltd. Beat Earnings Expectations And Analysts Now Have New Forecasts
Gelonghui Announcement Highlights: Shenzhen Mindray Bio-Medical Electronics: The net income attributable to the parent company in the first half of the year increased by 17.37% to 7.561 billion yuan, planning to distribute 40.6 yuan per 10 shares; Great W
【Performance Data】Anhui Anli Material Technology (300218.SZ): Net income in the first half of the year was 92.4078 million yuan, a year-on-year increase of 9821.08%. Spring Airlines (601021.SH): Net income in the first half of the year was 1.361 billion yuan, a year-on-year increase of 62.28%. Sunwoda Electronic (300207.SZ): Net income in the first half of the year was 0.824 billion yuan, a year-on-year increase of 87.89%. China Life Insurance (601628.SH): Net income in the first half of the year was 38.278 billion yuan, a year-on-year increase of 10.58%. Proposed dividend of 2 yuan for every 10 shares. China Pacific Insurance (601601.SH): Net income in the first half of the year was 25
Mindray Healthcare: 2024 Semi-Annual Report Summary
Mindray Healthcare: 2024 Semi-Annual Report
No Data
No Data